Precision Medicine for Neurodevelopmental Disorders

Time: 1:50 pm
day: Day One


• Addressing the pressing need to stratify and better characterise subpopulations of patients with neurodevelopmental disorders (NDDs) through omics-based precision medicine

• Integrating and analysing large datasets of genomic, proteomic, pharmacogenomic, anatomical, medical and clinical data

• DEPI technology is the first platform to enable the acceleration and derisking of clinical biomarker discovery and drug development in NDDs